BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24220145)

  • 1. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.
    Pfefferle AD; Herschkowitz JI; Usary J; Harrell JC; Spike BT; Adams JR; Torres-Arzayus MI; Brown M; Egan SE; Wahl GM; Rosen JM; Perou CM
    Genome Biol; 2013 Nov; 14(11):R125. PubMed ID: 24220145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
    Herschkowitz JI; Simin K; Weigman VJ; Mikaelian I; Usary J; Hu Z; Rasmussen KE; Jones LP; Assefnia S; Chandrasekharan S; Backlund MG; Yin Y; Khramtsov AI; Bastein R; Quackenbush J; Glazer RI; Brown PH; Green JE; Kopelovich L; Furth PA; Palazzo JP; Olopade OI; Bernard PS; Churchill GA; Van Dyke T; Perou CM
    Genome Biol; 2007; 8(5):R76. PubMed ID: 17493263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
    Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
    Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Signature Derived from Murine Tumor-Associated Macrophages Correlates with Poor Outcome in Breast Cancer Patients.
    Tuit S; Salvagno C; Kapellos TS; Hau CS; Seep L; Oestreich M; Klee K; de Visser KE; Ulas T; Schultze JL
    Cell Rep; 2019 Oct; 29(5):1221-1235.e5. PubMed ID: 31665635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
    Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.
    Hollern DP; Swiatnicki MR; Andrechek ER
    PLoS Genet; 2018 Jan; 14(1):e1007135. PubMed ID: 29346386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.
    Franks SE; Campbell CI; Barnett EF; Siwicky MD; Livingstone J; Cory S; Moorehead RA
    Oncogene; 2012 Jul; 31(27):3298-309. PubMed ID: 22020329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy.
    Pfefferle AD; Spike BT; Wahl GM; Perou CM
    Breast Cancer Res Treat; 2015 Jan; 149(2):425-37. PubMed ID: 25575446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.
    Colak D; Nofal A; Albakheet A; Nirmal M; Jeprel H; Eldali A; Al-Tweigeri T; Tulbah A; Ajarim D; Malik OA; Inan MS; Kaya N; Park BH; Bin Amer SM
    PLoS One; 2013; 8(5):e63204. PubMed ID: 23704896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.
    Hollern DP; Andrechek ER
    Breast Cancer Res; 2014 Jun; 16(3):R59. PubMed ID: 25069779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mouse models of breast cancer.
    Regua AT; Arrigo A; Doheny D; Wong GL; Lo HW
    Cancer Lett; 2021 Sep; 516():73-83. PubMed ID: 34090924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.
    Lim E; Wu D; Pal B; Bouras T; Asselin-Labat ML; Vaillant F; Yagita H; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2010; 12(2):R21. PubMed ID: 20346151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.
    Williams C; Helguero L; Edvardsson K; Haldosén LA; Gustafsson JA
    Breast Cancer Res; 2009; 11(3):R26. PubMed ID: 19426500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.